by Editor | Aug 28, 2024 | Abortion, Fetal & Vaccine Research, News
We recently published an update on seasonal influenza shots and very quickly received a number of questions about the use of mRNA technology in influenza shots. A brief mention was made in the update, but a little more detail will be useful in understanding the...
by Editor | Aug 25, 2024 | Abortion, Updates, Vaccines
Below you will find a summary of the approved influenza shots for this coming season. We found no material changes to the culturing method used for any of the approved vaccines, all of them using embryonated chicken eggs, specific pathogen-free eggs, MDCK canine cell...
by Editor | Sep 21, 2023 | Abortion, Fetal & Vaccine Research, Vaccines
Two RSV (Respiratory Syncytial Virus) vaccines have been approved in 2023 – Arexvy (GSK) and Abrysvo (Pfizer). Arexvy is recommended for adults over 60 years of age and Abrysvo has also been recommended for administration to expectant mothers between 32 and 36...
by Editor | Feb 28, 2023 | Exemptions, Legislative, News, Vaccines
The table was set for this when the Advisory Committee on Immunization Practices (ACIP) recommended the addition of COVID-19 vaccination to the child and adult immunization schedule, back in October of 2022. The vote was unanimous in support of the recommendation. The...
by Editor | Jan 29, 2023 | Abortion, Fetal & Vaccine Research, Legislative, News
The following item is the topic of our current weekly newsletter. This is a very encouraging development, as passage in Texas will have nationwide effects. Please take the time to make you support heard, whether you live in Texas or not. Call, email or send personal...
